WITH US
Ozempic Lawsuit for Gallbladder and Biliary Diseases
Recent medical studies have uncovered a troubling connection between Ozempic—a widely prescribed medication—and an increased risk of gallstone formation and other serious gallbladder complications. Known under various brand names such as Wegovy, Rybelsus, and by its generic name semaglutide, Ozempic is primarily used as an antidiabetic drug that helps regulate blood sugar levels in people living with type 2 diabetes. It also plays a role in weight management. The growing evidence linking Ozempic to these health issues calls for greater awareness and, in many cases, legal action for those who have been affected.
Your Guide to an Ozempic Gallbladder Lawsuit: A Resource by Mountaineer Criminal Law Group
If you’re wondering whether you can file an Ozempic gallbladder lawsuit, the answer is yes. The FDA’s Adverse Reporting System has received more than 10,000 reports of adverse events tied to Ozempic, and a large portion of these involve gallbladder-related complications, including gallstones and inflammation. If you were prescribed Ozempic and have since experienced gallbladder problems—such as cholelithiasis (gallstones)—you may have a valid claim for compensation. A Morgantown criminal lawyer at Mountaineer Criminal Law Group can offer a free consultation to review your case and help you pursue compensation for medical bills, lost wages, and pain and suffering.
Welcome to Mountaineer Criminal Law Group – Standing Up for Your Rights in Ozempic Cases
At Mountaineer Criminal Law Group, Morgantown criminal lawyers put the well-being and legal rights of consumers first—especially those who have been harmed by prescription medications. We are group believers in making sure people have access to complete and accurate information about the risks that come with the medications they are prescribed. Unfortunately, in the case of Ozempic, many patients were never properly warned about the risk of gallbladder complications, leading to serious and life-altering consequences for thousands of unsuspecting individuals.
As a personal injury law group with deep expertise in defective drug litigation, we are fully committed to fighting for what you deserve. Our team of Morgantown DUI attorney professionals and mass tort lawyers has successfully handled high-profile cases involving medications ranging from over-the-counter drugs like Tylenol and Zantac to prescription opioids and Elmiron. At Mountaineer Criminal Law Group, your voice matters, and we make sure it is heard.
Backed by more than 120 years of combined legal experience, we tackle every case with skill, perseverance, and unwavering commitment. Quality legal representation should be accessible to everyone—and at Mountaineer Criminal Law Group, we make that a reality. Let us guide you through your Ozempic gallbladder lawsuit and help you secure the compensation you are rightfully owed. Call Morgantown criminal lawyer today at (304) 832-8350 for a free consultation.
Mountaineer Criminal Law Group: A Proven Record of Legal Success
Our results speak for themselves. The award-winning team at Mountaineer Criminal Law Group has helped thousands of clients navigate complex legal challenges and obtain the financial compensation they needed to move forward after life-changing injuries. Some of our most notable achievements include:
- Securing settlements exceeding $400 million
- Achieving over 400 settlements that surpassed pre-trial offers
- Assisting more than 40,000 clients
- Drawing on more than 120 years of combined legal experience
Whether you are exploring your options or are ready to take action, a Morgantown criminal lawyer at our group is available to walk you through every step of the process.
Ozempic: What You Need to Know
Ozempic is a well-established antidiabetic medication used to manage type 2 diabetes without the use of insulin. Developed by Novo Nordisk, a Danish pharmaceutical company, in 2012, Ozempic transformed the landscape of diabetes treatment by offering the dual benefit of regulating blood sugar and supporting weight management.
With approximately 4 million prescriptions filled in the United States—ranking it 129th among the most commonly prescribed drugs—Ozempic has become a mainstream treatment option. However, it is not appropriate for individuals with type 1 diabetes, diabetic ketoacidosis, or a prior history of pancreatitis.
How Ozempic Works and Its Benefits
Ozempic contains semaglutide, which belongs to a class of drugs known as GLP-1 Receptor Agonist Analogs. By mimicking the effects of the human hormone glucagon-like peptide-1 (GLP-1), the medication triggers insulin secretion and helps regulate glucose metabolism—offering a multi-pronged approach to diabetes management.
Put simply, Ozempic signals the pancreas to release insulin when blood sugar levels rise, while also curbing the liver’s excessive production and release of sugar. This dual action makes it particularly effective in addressing the irregular blood sugar patterns seen in people with type 2 diabetes.
Ozempic is administered as a liquid solution using a prefilled disposable pen and is typically prescribed as a once-weekly injection into the abdomen, thigh, or upper arm.
Ozempic Side Effects: Risks and Injuries to Be Aware Of
If you or someone close to you has experienced complications after using Ozempic, it is essential to understand the potential health risks linked to this medication. Clinical research has shown that drugs in the same class as Ozempic carry a greater likelihood of causing gallbladder problems, including the development of gallstones (cholelithiasis), which can cause severe pain and lead to serious complications. A Morgantown DUI attorney at Mountaineer Criminal Law Group can help you understand your legal options if you have experienced these side effects.
What is Cholelithiasis (Gallstones)?
Cholelithiasis occurs when cholesterol and bilirubin harden and form stones inside the gallbladder. The gallbladder is a small organ that stores bile produced by the liver—an important component of the digestive process. When gallstones block the ducts of the gallbladder, bile begins to accumulate, resulting in sudden and intense pain, often referred to as a gallbladder attack. In many cases, surgical intervention—known as cholecystectomy—is required. Common symptoms of cholelithiasis include:
- Sudden pain in the upper right or center of the abdomen, or in the shoulders
- Nausea
- Vomiting
What is Cholecystitis?
Cholecystitis refers to inflammation of the gallbladder, usually caused by gallstones blocking the bile ducts. As the gallbladder fills with bile and digestive fluids, it becomes inflamed. If left untreated, this condition can escalate to a gallbladder rupture—a serious and potentially life-threatening complication. Surgical removal of the gallbladder is the standard course of treatment. Common symptoms of cholecystitis include:
- Abdominal pain
- Back and shoulder pain
- Nausea
- Vomiting
- Fever
Ozempic and Gastroparesis: Understanding the Connection and Legal Ramifications
Emerging reports have identified a link between Ozempic use and a condition known as gastroparesis—a disorder in which the stomach muscles function slowly or irregularly, preventing food from being properly digested. Often described as stomach paralysis, gastroparesis can cause chronic pain, nausea, vomiting, and bloating.
As more individuals come forward with accounts of stomach paralysis after taking Ozempic, legal proceedings are being initiated to hold responsible parties accountable. Other medications—including Wegovy, Mounjaro, Rybelsus, Trulicity, and Saxenda—have also been associated with gastroparesis and may be subject to their own product liability claims.
If you or a loved one has experienced these complications after using any of these medications, speaking with a Morgantown criminal lawyer can help you understand your rights and identify your available legal options.
How Much Is an Ozempic Lawsuit Worth?
A common question among prospective plaintiffs involves the financial value of an Ozempic lawsuit. While there is no universal answer, the value of each case depends heavily on the specific damages suffered by the individual. Losses tied to injuries such as gallstones must be carefully assessed and quantified before a figure can be determined.
Gallbladder issues caused by Ozempic can carry significant financial consequences, including costly medical procedures, lost income due to missed work, and in some cases, loss of employment altogether. In addition to these economic damages, the non-economic impact of ongoing pain and suffering also forms a critical component of legal compensation.
Settlement estimates for Ozempic-related gallbladder cases typically range from $400,000 to $700,000, with the higher end reserved for cases involving gallbladder removal or, in the most severe instances, wrongful death. Connecting with a Morgantown DUI attorney who handles drug injury cases can help you maximize the value of your claim and ensure no damages are overlooked. Contact Mountaineer Criminal Law Group at (304) 832-8350 to get started.
Understanding Legal Damages in an Ozempic Lawsuit
If Ozempic has caused you harm, it is important to understand the range of legal damages potentially available to you. Being informed about these categories can help you approach the legal process with greater confidence and increase the likelihood of a favorable outcome.
Economic Damages
Economic damages refer to tangible, quantifiable financial losses that can be documented through bills, records, or receipts. In an Ozempic lawsuit, these may include:
- Current and future medical expenses
- Loss of income due to missed work or changes in employment status
- Additional out-of-pocket costs directly linked to your injuries
Non-Economic Damages
Non-economic damages are more difficult to assign a dollar value to, as they lack concrete documentation—but they are equally valid in the eyes of the law. These may include:
- Pain and suffering
- Loss of personal relationships
- Diminished enjoyment of life
- Grief and loss in cases where a loved one has passed away as a result of Ozempic use
Partnering with an experienced Morgantown criminal lawyer at Mountaineer Criminal Law Group ensures that all applicable damages are thoroughly identified, assessed, and pursued on your behalf.
What Medical Research Says About Ozempic and Gallbladder Health
Clinical trial data has revealed concerning findings about Ozempic’s impact on gallbladder health. According to the drug’s product label, gallstone development was observed in 1.5% of patients receiving a 0.5mg dose and 0.4% of patients on a 1mg dose—while no such occurrences were recorded in the placebo group. Perhaps more alarming, 90% of patients who developed gallstones during these trials required a cholecystectomy (surgical gallbladder removal), underscoring the serious nature of this complication. A Morgantown DUI attorney who understands pharmaceutical litigation can help you interpret how this data applies to your case.
Multiple peer-reviewed studies published in reputable medical journals have since corroborated the link between GLP-1 receptor agonist drugs like Ozempic and a heightened risk of gallbladder-related disease, reinforcing the need for careful consideration when this medication is prescribed.
Meta-Analysis Published in JAMA Internal Medicine: GLP-1 Receptor Agonists and Gallbladder Disease
A major study published in JAMA Internal Medicine examined the association between GLP-1 receptor agonist (RA) use and the risk of gallbladder and biliary diseases. This wide-ranging meta-analysis reviewed randomized clinical trials involving adult patients, comparing the effects of GLP-1 RA drugs against placebos or non-GLP-1 RA medications.
The results revealed a statistically significant increase in the risk of both cholelithiasis (RR 1.27; 95% CI 1.10–1.47) and cholecystitis (RR 1.36; 95% CI 1.14–1.62) among patients using GLP-1 RAs. The study also established a clear relationship between the risk of gallbladder or biliary disease and factors such as dosage strength, duration of use, and weight loss applications of GLP-1 RAs—highlighting the need for greater caution in clinical practice.
JAMA Internal Medicine Study: Incretin-Based Drugs and Bile Duct/Gallbladder Disease in Type 2 Diabetes Patients
Another significant study published in JAMA Internal Medicine investigated the relationship between DPP-4 inhibitors, GLP-1 analogues, and the elevated risk of bile duct and gallbladder diseases in patients with type 2 diabetes. Analyzing data from 71,369 patients, the research identified 853 individuals who were hospitalized due to bile duct and gallbladder complications.
The study found a clear correlation between the use of GLP-1 analogues and an increased likelihood of developing these serious conditions. Additionally, GLP-1 analogue use was associated with a higher probability of requiring cholecystectomy—a finding that strongly supports the case for greater regulatory scrutiny and informed patient consent. A Morgantown criminal lawyer can help you build a strong legal argument using this kind of clinical evidence.
Meta-Analysis in Diabetes Research and Clinical Practice: GLP-1 RAs and Cholelithiasis Risk
A meta-analysis featured in Diabetes Research and Clinical Practice shed further light on the link between GLP-1 receptor agonists and cholelithiasis. Drawing on updated trial data, the study found an elevated risk of gallstone development among patients using GLP-1 RAs (MH-OR 1.28; 95% CI 1.11–1.48). Sensitivity analysis with continuity correction reinforced this finding (MH-OR 1.26; 95% CI 1.10–1.45) when compared to placebo or active comparators. These findings carry significant implications for healthcare providers when evaluating GLP-1 RAs as part of a patient’s treatment plan.
Safety Review in Diabetes, Obesity & Metabolism: GLP-1 RAs and Cholelithiasis
A meta-analysis published in Diabetes, Obesity & Metabolism reviewed the safety profile of GLP-1 receptor agonists with a focus on their impact on pancreatitis, pancreatic cancer, and cholelithiasis. The study incorporated data from recent cardiovascular outcome trials (CVOTs) involving GLP-1 RAs. While the findings confirmed the relative safety of GLP-1 receptor agonists with respect to pancreatitis, they also flagged a notable increase in the risk of cholelithiasis. These insights are valuable for clinicians and patients alike when weighing the benefits and risks of GLP-1 RA therapy. Speaking with a Morgantown DUI attorney well-versed in pharmaceutical litigation can help you put this research to work in support of your case.
Mountaineer Criminal Law Group: Compassionate Legal Support for Ozempic Victims in Morgantown, West Virginia
Dealing with the aftermath of a serious drug complication is overwhelming—especially when you’re facing mounting medical bills, lost income, reduced earning potential, and significant emotional distress. You don’t have to go through it alone. The Mountaineer Criminal Law Group is here to stand by your side throughout the legal process. Our nationally recognized team of Morgantown DUI attorneys has earned the trust of countless clients across West Virginia who can speak to our dedication and results.
Do You Qualify for an Ozempic Gallbladder Lawsuit?
To be eligible to file an Ozempic gallbladder lawsuit with our group, you or your loved one must meet the following criteria:
- Prior use of Ozempic before April 2022
- A confirmed diagnosis of gallbladder disease
- Receipt of medical treatment for the gallbladder condition
If these circumstances apply to you, a Morgantown criminal lawyer is ready to help. Take the first step toward justice by reaching out to our team today for a complimentary consultation. Our West Virginia Ozempic attorneys will compassionately support you in seeking compensation for conditions such as cholelithiasis or cholecystitis linked to Ozempic use.
Call Morgantown DUI attorney now at (304) 832-8350. Our team is ready to help you pursue the resolution you deserve.











